Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review
CRD SUMMARY: The authors concluded that low molecular weight heparin could not be recommended routinely and that further trials were required to test patient-specific endpoints. The authors' conclusions were appropriate for the evidence presented.
